Ledger.Open graph →
SEC Form D · filed December 4, 2025

Triana Biomedicines, Inc

Offering
$120.1M
Sold
$120.1M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
LEXINGTON, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (16)

Andrew Hedin · Cambridge, MADirectorChristopher O'Donnell · Austin, TXDirectorPatrick Trojer · Lexington, MAExec · DirectorShelley Chu · San Diego, CADirectorJoshua Resnick · Los Angeles, CADirectorJigar Raythatha · Waltham, MADirectorLorence Kim · Cambridge, MADirectorPatrick Trojer · Lexington, MAExec · DirectorJigar Raythatha · Waltham, MADirectorAndrew Hedin · Cambridge, MADirectorJoshua Resnick · Needham, MADirectorLorence Kim · Cambridge, MADirectorDavid Grayzel · Cambridge, MADirectorDavid Grayzel · Cambridge, MADirectorShelley Chu · San Diego, CADirectorChristopher O'Donnell · Rochester, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗